Progia Medical Inc.

Progia Medical is a Minneapolis-based medical device manufacturer specializing in dysphagia therapy solutions. The company has developed the Swallow Therapy System™ (STS™), the first technically enhanced dysphagia therapy system that combines objective tongue strength measurement with data-driven biofeedback to improve swallowing function and patient outcomes. Founded in 2023 by Ross Dunbar and Gary Graham, Progia built its technology on groundbreaking research from the University of Wisconsin School of Medicine & Public Health and Madison VA Hospital. The STS™ platform offers customized treatment plans tailored to each patient's unique swallowing deficits, utilizing isometric progressive resistive exercise principles to enhance swallowing safety and reduce dysphagia severity. With over 11 million dysphagia cases diagnosed annually in the US and an aging population projected to exceed 19% by 2030, the need for device-assisted therapy is substantial. Progia manufactures its products in the USA under ISO 13485 standards and holds FDA Class I registration. The company is Veteran and Disabled-owned and emphasizes patient-centric design, safety, quality, and clinical efficacy.